"Remission Induction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapeutic act or process that initiates a response to a complete or partial remission level.
| Descriptor ID |
D012074
|
| MeSH Number(s) |
E02.860
|
| Concept/Terms |
Remission Induction- Remission Induction
- Induction, Remission
- Inductions, Remission
- Induction of Remission
- Remission Inductions
|
Below are MeSH descriptors whose meaning is more general than "Remission Induction".
Below are MeSH descriptors whose meaning is more specific than "Remission Induction".
This graph shows the total number of publications written about "Remission Induction" by people in this website by year, and whether "Remission Induction" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 4 | 4 |
| 2014 | 0 | 7 | 7 |
| 2015 | 0 | 7 | 7 |
| 2016 | 0 | 6 | 6 |
| 2017 | 6 | 125 | 131 |
| 2018 | 6 | 145 | 151 |
| 2019 | 5 | 53 | 58 |
| 2020 | 1 | 4 | 5 |
| 2021 | 0 | 6 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Remission Induction" by people in Profiles.
-
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry. J Crohns Colitis. 2021 Nov 08; 15(11):1846-1851.
-
Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis. Rheumatology (Oxford). 2021 10 09; 60(SI):SI3-SI12.
-
COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab. Nephrol Dial Transplant. 2021 08 27; 36(9):1758-1760.
-
Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey. Rheumatol Int. 2021 Nov; 41(11):1941-1947.
-
A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns. Immunopharmacol Immunotoxicol. 2021 Oct; 43(5):507-518.
-
Sequential dosing of convalescent COVID-19 plasma with significant temporal clinical improvements in a persistently SARS-COV-2 positive patient. Transfus Apher Sci. 2021 Oct; 60(5):103180.
-
COVID-19 in Lung Transplant Recipients: 2 Cases With Acute Respiratory Distress Syndrome Successfully Treated With High-Dose Corticosteroids. Exp Clin Transplant. 2021 07; 19(7):744-748.
-
Genetics of symptom remission in outpatients with COVID-19. Sci Rep. 2021 05 25; 11(1):10847.
-
Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus Disease 2019. Circ J. 2021 05 25; 85(6):944-947.
-
Proteinuria changes in kidney disease patients with clinical remission during the COVID-19 pandemic. PLoS One. 2021; 16(4):e0250581.